Clinical Trials List
Protocol NumberHR-11-001
2013-06-01 - 2013-12-31
Others
Terminated1
-
Trial Applicant
INNOPHARMAX INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
9 participants
